Drug Profile
Research programme: cancer diagnostics - Patrys/Macquarie University/Minomic International
Alternative Names: Nanocrystal fluorescent technology - Cancer diagnostics; Super dot nanocrystal-labelled PAT-SM6Latest Information Update: 24 Mar 2023
Price :
$50
*
At a glance
- Originator Macquarie University; Minomic International; Patrys
- Class Monoclonal antibody diagnostics
- Mechanism of Action Single-photon emission-computed tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 24 Mar 2023 Discontinued - Preclinical for Cancer (Diagnosis) in Australia (IV)
- 28 Jul 2020 No recent reports of development identified for preclinical development in Cancer(Diagnosis) in Australia (IV, Infusion)
- 14 Jun 2016 Preclinical trials in Cancer (Diagnosis) in Australia (IV) before June 2016